Switch to: Citations

Add references

You must login to add references.
  1. A Non-Paternalistic Model of Research Ethics and Oversight: Assessing the Benefits of Prospective Review.Alex John London - 2012 - Journal of Law, Medicine and Ethics 40 (4):930-944.
    To judge from the rash of recent law review articles, it is a miracle that research with human subjects in the U.S. continues to draw breath under the asphyxiating heel of the rent-seeking, creativity-stifling, jack-booted bureaucrethics that is the current system of research ethics oversight and review. Institutional Review Boards, sometimes called Research Ethics Committees, have been accused of perpetrating “probably the most widespread violation of the First Amendment in our nation's history,” resulting in a “disaster, not only for academics, (...)
    Download  
     
    Export citation  
     
    Bookmark   22 citations  
  • Stem Cell Tourism and the Power of Hope.Charles E. Murdoch - 2010 - American Journal of Bioethics 10 (5):16-23.
    This paper explores the notions of hope and how individual patient autonomy can trump carefully reasoned ethical concerns and policies intended to regulate stem cell transplants. We argue that the same limits of knowledge that inform arguments to restrain and regulate unproven treatments might also undermine our ability to comprehensively dismiss or condemn them. Incautiously or indiscriminately reasoned policies and attitudes may drive critical information and data underground, impel patients away from working with clinical researchers, and tread needlessly on hope, (...)
    Download  
     
    Export citation  
     
    Bookmark   21 citations  
  • Access to Unapproved Medical Interventions in Cases of Catastrophic Illness.Udo Schuklenk - 2014 - American Journal of Bioethics 14 (11):20-22.
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • Stem Cell Tourism and the Power of Hope.Charles E. Murdoch & Christopher Thomas Scott - 2010 - American Journal of Bioethics 10 (5):16-23.
    This paper explores the notions of hope and how individual patient autonomy can trump carefully reasoned ethical concerns and policies intended to regulate stem cell transplants. We argue that the same limits of knowledge that inform arguments to restrain and regulate unproven treatments might also undermine our ability to comprehensively dismiss or condemn them. Incautiously or indiscriminately reasoned policies and attitudes may drive critical information and data underground, impel patients away from working with clinical researchers, and tread needlessly on hope, (...)
    Download  
     
    Export citation  
     
    Bookmark   25 citations  
  • The Importance of Trust for Ethics, Law, and Public Policy.Mark A. Hall - 2005 - Cambridge Quarterly of Healthcare Ethics 14 (2):156-167.
    The importance of preserving trust in physicians and in medical institutions has received widespread attention in recent years. Primarily, this is due to the threats to trust posed by managed care, but there is a general and growing recognition that trust deserves more attention than it traditionally has received in all aspects of medical ethics, law, and public policy. Trust has both intrinsic and instrumental value. Trust is intrinsically important because it is a core characteristic that affects the emotional and (...)
    Download  
     
    Export citation  
     
    Bookmark   16 citations  
  • Insights from Patients' Blogs and the Need for Systematic Data on Stem Cell Tourism.Aaron D. Levine - 2010 - American Journal of Bioethics 10 (5):28-29.
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • Allowing Innovative Stem Cell-Based Therapies outside of Clinical Trials: Ethical and Policy Challenges.Insoo Hyun - 2010 - Journal of Law, Medicine and Ethics 38 (2):277-285.
    Armed with expanded federal funding for human embryonic stem cell research and new methods for deriving pluripotent stem cells, stem cell researchers in the U.S. are poised to proceed with unprecedented speed toward the development of new clinical therapies. Staring into the new dawn of regenerative medicine, many observers may assume that the only responsible route to the clinic, both scientifically and ethically, is through FDA-approved clinical trials processes. Conventional wisdom dictates that, like pharmaceutical drugs and the use of biological (...)
    Download  
     
    Export citation  
     
    Bookmark   9 citations  
  • Hope, Hype and Help: Ethically Assessing the Growing Market in Stem Cell Therapies.Arthur Caplan & Bruce Levine - 2010 - American Journal of Bioethics 10 (5):24-25.
    Download  
     
    Export citation  
     
    Bookmark   1 citation